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Edited by Robert BaroukiAbstract Phosphatidylinositol 3-kinases (PI3K) phosphorylate
the 3-position of the inositol ring of phosphatidylinositol-4,5-bis-
phosphate to produce phosphatidylinositol-3,4,5-trisphosphate.
It is not clear whether PI3K can phosphorylate the inositol group
in other biomolecules. We sought to determine whether PI3K
was able to use glycosyl-phosphatidylinositol (GPI) as a sub-
strate. This phospholipid may exist either in free form (GPIfree)
or forming a lipid anchor (GPIanchor) for the attachment of
extracellular proteins to the plasma membrane. We demonstrate
the speciﬁc PI3K-mediated phosphorylation of the inositol 3-hy-
droxyl group within both types of GPI by incubating this
phospholipid with immunoprecipitated PI3K. The phosphory-
lated product behaves in HPLC as a derivative of a PI3K lipid
product. To our knowledge, this is the ﬁrst demonstration that
PI3K uses lipid substrates other than phosphoinositides. Further,
we show that this has potential functional consequences. When
GPIfree is phosphorylated, it becomes a poorer substrate for
GPI-speciﬁc phospholipase D, but a better substrate for phos-
phatidylinositol-speciﬁc phospholipase C. These phosphorylation
events may constitute the basis of a previously undescribed signal
transduction mechanism.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Phosphoinositides are now widely recognized as playing key
roles in both signal transduction pathways and in the control
of multiple intracellular activities [1]. Two signal transduction
pathways involving inositol-containing phospholipids have
been characterized to date. The best characterized is the one*Corresponding author. Fax: +31205121989.
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doi:10.1016/j.febslet.2004.11.035involving agonist-stimulated generation of the second messen-
gers diacylglycerol and inositol-1,4,5-triphosphate, respectively
causing activation of protein kinase C and liberation of calcium
ions from intracellular stores [2–4]. In addition, a new family of
3-phosphorylated phosphoinositides has been identiﬁed in cells
that are derived through the action of PI3K. There are three
structurally distinct classes of PI3K [5]. The Class I PI3K sub-
family is activated as a consequence of the stimulation of recep-
tor tyrosine kinases/G-protein coupled receptors causing the
initial production of phosphatidylinositol-3,4,5-trisphosphate
(PtdIns3,4,5P3) from its preferred substrate PtdIns4,5P2 [6].
The Class II PI3K subfamily preferentially uses phosphatidylin-
ositol-4-monophosphate (PtdIns4P) and phosphatidylinositol
(PtdIns) as substrates, generating phosphatidylinositol-3,4-bis-
phosphate (PtdIns3,4P2) and phosphatidylinositol 3-mono-
phosphate (PtdIns3P) [7,8]. Finally, Class III PI3K is only
able to generate PtdIns3P [9]. Our understanding of the conse-
quences of PI3-K activation derives mainly from studies on the
Class I family. Our current view is that activation of PI3K leads
to a plethora of cell responses, including cell proliferation, cell
diﬀerentiation, cell survival and cell motility [10,11].
Glycosyl-phosphatidylinositol (GPI) lipids display a dual
role, as anchors for membrane-associated proteins and as pro-
tein-free precursors for the generation of biologically active
IPG molecules [12–16]. GPIfree consists of PtdIns bound to a
2-amino-2-deoxy-a-D-glucopyranose through a 1-D–4-O-
bond. The latter is subsequently linked to a phosphorylated
glycan. GPIfree is strongly implicated in mediating numerous
actions of hormones, resulting in metabolic changes within
the cell, and of growth factors and cytokines, leading to prolif-
eration and diﬀerentiation [12–14]. In response to insulin, the
classical PtdIns cycle is not activated. In contrast, both the
GPIfree and the PI3K pathways are activated. Failure to do
so results in the loss of the metabolic actions of insulin
[13,17]. Although the PI3K family of enzymes is known to
phosphorylate PtdIns, PtdIns4P, and PtdIns4,5P2, there are
no reports in the literature concerning enzymatic phosphoryla-
tion of the inositol moiety of GPIfree nor of GPIanchor. In the
present paper, we describe the speciﬁc in vitro 3-phosphoryla-
tion of the inositol ring within GPIfree (isolated from rat liver)
and also of GPIanchor [isolated from bovine erythrocyte acetyl-
choline esterase (AChE)] by mammalian Class I PI3K. As ablished by Elsevier B.V. All rights reserved.
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some control on the metabolic actions of insulin as GPIfree–P
displays a diﬀerent susceptibility to hydrolysis by speciﬁc phos-
pholipases. This would constitute a third, novel signal trans-
duction pathway involving phosphoinositides.2. Materials and methods
2.1. Materials
[c32P]ATP (speciﬁc activity 3000 Ci/mmol) was purchased from
Amersham Pharmacia Biotech (Amersham, UK). Foetal calf serum,
cell culture media and supplements were supplied by Gibco (Paisley,
UK). Silica gel thin layer chromatography (TLC) plates (60 A˚, LK6D)
were from Whatman (Maidstone, UK). The anti-p85 antibody was
from Upstate Biotechnology Inc (Waltham, MA, USA). Phosphatidyl-
choline (PtdCho), phosphatidylethanolamine (PtdEth), phosphatidic
acid (PtdOH), PtdIns4P, PtdIns, wortmanin, LY294002, and protein-
A Sepharose were from Sigma (Poole, UK). Authentic radiolabelled
standards for strong ion exchange-high performance liquid chroma-
tography (SAX-HPLC) were prepared as previously described [18].
phosphatidylinositol-speciﬁc phospholipase C (PI-PLC) (Bacillus thur-
ingiensis) was from Molecular Probes Inc. (Eugene, OR, USA) and
bovine brain GPI-speciﬁc phospholipase (GPI-PLD) was puriﬁed as
reported [19]. Salts, organic solvents and other reagents were of analyt-
ical grade and were supplied by Merck (Darmstadt, Germany).
2.2. Puriﬁcation of GPIfree and GPIanchor
GPIfree was puriﬁed as detailed [20]. Brieﬂy, total lipids isolated by
CHCl3/MeOH/HCl extraction of 30 rat livers were applied to the ori-
gin of heat-activated TLC plates. The plates were then developed twice
in the acidic solvent system consisting of CHCl3/CH3COCH3/MeOH/
CH3COOH/H2O (10/4/2/2/1, v/v). The material remaining at the origin
(from 0.5 cm below to +1 cm above) was eluted from the silica by
washing three times with methanol. The eluted material was dried un-
der a gentle stream of nitrogen gas before it was applied to a further set
of TLC plates for development in the basic solvent system consisting of
CHCl3/MeOH/16 M NH3/H2O (45/45/3.5/10, v/v). GPI
free was located
between the authentic standards PtdOH and PtdCho, which had been
spotted onto the plates. Conﬁrmation that GPIfree was indeed the lipid
migrating at the stated position was achieved by noting its reactions
with iodine vapour, 1,6-diphenylhexatriene (both general lipid stains),
the orcinol reagent (speciﬁc for sugar residues), ninhydrin (amino
group detector) and the molybdenum blue reagent (for phosphate).
GPIfree that had not been exposed to the detecting reagents was re-
moved from the silica using methanol as described above. The yield
of GPIfree was calculated from its free amino group content and its to-
tal number of phosphate groups measured by previously published
methods [21]. It has been proposed that the stoichiometry of the num-
ber of phosphate groups to free amino groups is 3:1 [21]. To conﬁrm
the absence of polyunsaturated fatty acids (to rule out the possibility
of contamination of the GPIfree preparation by phosphoinositides),
gas chromatography-mass spectrometry (GC/MS) was used as previ-
ously described [22]. Acetylcholinesterase from bovine erythrocytes
was puriﬁed as described [23]. To the pure enzyme (1.1 mg in 2.5 ml
of 20 mM Tris–HCl, pH 7.4, containing 5 mM CaCl2 and 0.05% Tri-
ton-X 100), 3.2 mg pronase (F. Hoﬀmann-La Roche Ltd., Basel, Swit-
zerland) was added and the mixture incubated for 21 h at 37 C. The
GPIanchor was puriﬁed by chromatography on an octyl-Sepharose col-
umn (1.5 ml) as described [24]. In order to separate the GPIanchor from
the peptides that resulted from the pronase digestion, the column was
ﬁrst washed with 10 ml of 5% propan-1-ol in 0.1 M ammonium acetate
buﬀer, pH 7.0, followed by 35 ml of 20% propan-1-ol in the same buf-
fer. The GPIanchor was then eluted with 40% propan-1-ol in ammonium
acetate buﬀer. Anchor containing fractions were pooled and concen-
trated by evaporation under nitrogen.
2.3. Class I PI3-K immunoprecipitation and phosphorylation of
substrates
The IL-2-dependent murine T-lymphocyte cell line CTLL-2 was
maintained in suspension culture as previously described [18]. 1 · 108
cells obtained from an exponentially growing culture were washed
twice in PBS before their lysis in ice-cold lysis buﬀer (150 mM NaCl,50 mM NaF, 1% v/v NP-40, 1 mM EDTA, 1 mM orthovanadate, 10
lg/ml leupeptin, 10 lg/ml aprotinin, and 1 mM phenylmethylsulfonyl
ﬂuoride) for 15 min. After centrifugation at 4 C for 15 min at
20800 · g, the cleared supernatant was mixed with 5 lg of anti-p85
antibody. Immunoprecipitation was allowed to proceed for 2 h at 4
C with gentle agitation. Protein-A Sepharose (approximately 80 ll
packed volume) was then added and the mixing was continued for a
further one hour. The Sepharose beads were then washed twice with
lysis buﬀer, twice with 0.5 M LiCl and ﬁnally twice with PI3K assay
buﬀer (50 mM Tris–HCl, pH 7.4). The immunoprecipitate was divided
into two portions. 90% was used for the phosphorylation of either
GPIfree or GPIanchor, whereas 10% was used to phosphorylate PtdIns.
The substrates (10 nmol of GPIfree, 5 lg GPIanchor or 1 nmol of PtdIns)
were sonicated (10 min at room temperature) into 20 ll of PI3K assay
buﬀer. The ﬁnal reaction conditions contained ATP at 20 lM, MgCl2
at 10 mM and 25 lCi [c32P]ATP in a ﬁnal volume of 50 ll. The reac-
tion was allowed to proceed at room temperature for 15 min before the
extraction of lipids with CHCl3/MeOH/HCl. The CHCl3 phase was ta-
ken into a clean glass tube and dried under a gentle stream of nitrogen
gas. After resuspending in chloroform, a portion of the samples was
applied to a TLC plate, which was developed in a basic solvent system
(see above). After development, the TLC plate was allowed to dry be-
fore staining with iodine vapour. Authentic phospholipid standards
(including unlabelled GPIfree), which had been applied to the TLC
plate alongside the samples, were visualized as brown spots. The posi-
tions of phosphorylated products were determined by autoradiogra-
phy. In some experiments, human embryonic kidney ﬁbroblasts
(HEK-293 cells) were used as a source for Class II PI3K activity [25].
2.4. Nitrous acid deamination of reaction products and their analysis by
SAX-HPLC
The remaining portion of the samples was dried under a gentle
stream of nitrogen gas before treatment with nitrous acid, as previ-
ously described [21]. The deacylation of the radiolabelled lipids was
achieved using methylamine. The deacylated radiolabelled lipids were
analyzed by SAX-HPLC as described previously [18]. In some experi-
ments, the nitrous acid deamination step was omitted in order to exam-
ine the phosphorylation state of deacylated GPIfree–P by SAX-HPLC.
2.5. Hydrolysis of GPIfree and GPIfree–P by phospholipases
Puriﬁed GPIfree or GPIfree–P (obtained by cold phosphorylation of
rat liver-derived GPIfree by PI3K and its subsequent puriﬁcation by
TLC) were reconstituted asymmetrically into preformed liposomal
membranes as described previously [26]. Brieﬂy, large unilamellar ves-
icles composed of PtdEth/PtdCho (2:1 mole ratio) were prepared by
the extrusion method [27], using 0.1 lm pore diameter Nuclepore ﬁlters
at room temperature, as detailed previously [28]. Total lipid concentra-
tion was adjusted to 80 lM after lipid phosphate analysis. Then, the
appropriate amount of GPIfree or GPIfree–P was dissolved in methanol
and mixed with the liposomes in buﬀer, so that the GPIfree (or GPIfree–
P) mole fraction in the lipid was 10%, unless otherwise stated, and the
volume of the methanolic solution was 5% of the vesicle suspension.
The resulting mixture was left to incubate for 15 min at room temper-
ature. This causes GPIfree and GPIfree–P to become asymmetrically in-
serted into the outer monolayer of the vesicles. The resulting
suspension was then used in the phospholipase assays using the en-
zymes previously described [22,26]. The assays were linear with respect
to time and enzyme concentration.
2.6. Data presentation
Unless speciﬁed otherwise, data are presented as representative re-
sults from at least three independent experiments. Enzyme activity
data are averages of two closely similar independent measurements.3. Results and discussion
Insulin is a hormone that simultaneously activates multiple
signal transduction pathways, including the generation of
IPG [13,29–31] and the activation of PI3K [17]. In order to
study possible crosstalk between these two apparently distinct
pathways in a cell-free system, we decided to determine
Fig. 2. SAX-HPLC analysis of the in vitro phosphorylation of GPIfree
and PtdIns by PI3K. GPIfree and PtdIns were used as substrates for in
vitro PI3K phosphorylation. The radiolabelled products were then
treated with nitrous acid before deacylation. The deacylated lipids were
analyzed by SAX-HPLC. Panel A indicates the SAX-HPLC proﬁle of
GroPIns3P and GroPIns4P derived from authentic [32P]PtdIns3P and
[3H]PtdIns4P. Panel B indicates the SAX-HPLC proﬁle of PtdIns,
which had been previously phosphorylated by PI3K, treated with
nitrous acid and deacylated. Panel C indicates the SAX-HPLC proﬁle
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substrates for a 3-phosphorylation reaction and (ii) whether
GPIfree–P was susceptible to hydrolysis by the enzymes GPI-
PLD and PI-PLC.
Class I PI3K was immunoprecipitated and incubated with
either GPIfree (puriﬁed from rat liver) or commercially avail-
able PtdIns in the presence of [c32P]ATP. The reaction prod-
ucts were extracted with CHCl3/MeOH before being
separated by TLC. Fig. 1 shows the autoradiogram of the
TLC plate. When the substrate was PtdIns, a radiolabelled
spot ([32P]PtdIns3P) that coincided with the unlabelled authen-
tic PtdIns4P was seen. It must be noted that the solvent system
employed in the TLC was unable to separate PtdIns3P from
PtdIns4P. When GPI was presented as the substrate, a radio-
labelled spot with a Rf of approximately 0.43 was observed.
Its migration was very similar to that of [32P]PtdIns3P and
the unlabelled authentic PtdIns4P. This spot was putatively
identiﬁed as [32P]GPIfree-P.
In order to determine where the [32P] was incorporated in the
[32P]GPIfree–P, it was necessary to chemically break down the
structure for its analysis by HPLC. [32P]GPIfree–P was treated
with nitrous acid to break the bond between inositol and glu-
cosamine, yielding a PtdIns moiety and free glycan. The [32P]
radioactivity was found within the PtdIns moiety and not with
the free glycan. The last step in the analysis was to determine
the position of the [32P]phosphate group within the inositolFig. 1. TLC analysis of the in vitro phosphorylation of GPIfree and
PtdIns by PI3K. GPIfree and PtdIns were used as substrates for in vitro
PI3K phosphorylation. A portion of the radiolabelled products was
applied to a TLC plate followed by its development in a basic solvent
system. [32P]GPIfree–P migrated with an Rf of approximately 0.43,
coinciding with that of [32P]PtdIns3P. The migration positions of the
authentic phospholipid standards are indicated. The broken circle
shows where non-radiolabelled GPIfree migrated (revealed by iodine
staining).
of GPIfree, which had been previously phosphorylated by PI3-K,
treated with nitrous acid and deacylated. Panel D shows the SAX-
HPLC proﬁle of the deacylated reaction products of GPIfree, which
had been previously phosphorylated by PI3K. The asterisks indicate
peaks that may correspond to a family of diﬀerentially 3-phosphor-
ylated GroPIns-glycan species. The numbers that appear within the
SAX-HPLC proﬁle in panel D refer to the position of authentic
standards. 1, Gro3P; 2, inorganic phosphate 3, glycerophosphoinos-
itol-3,5-bisphosphate; 4, glycerophosphoinositol-3,4-bisphosphate; 5,
glycerophosphoinositol-4,5-bisphosphate; 6, ATP; 7, glycerophosphoi-
nositol-3,4,5-trisphosphate.ring. After deacylation, the GroPIns[32P]phosphate was sub-
jected to SAX-HPLC. The results of the SAX-HPLC analysis
are shown in Fig. 2. In panel A, the authentic deacylated prod-
ucts of [32P]PtdIns3P and [3H]PtdIns4P ([32P]GroPIns3P and
[3H]GroPIns4P, respectively) are clearly separated from one
another, with retention times of 39.5–40 min and 43.5–44
min, respectively. In order to determine if acid-catalyzed
migration of the [32P]phosphate group around the inositol ring
occurred during nitrous acid treatment of [32P]GPIfree–P (for
example, from position 3 to position 4), authentic
[32P]PtdIns3P was subjected to nitrous acid deamination in
parallel to that of [32P]GPIfree–P. Panel B clearly shows that
when [32P]PtdIns3P was taken through the whole procedure,
over 90% of the radioactivity was present in the peak corre-
sponding to [32P]GroPIns3P, thereby ruling out this cause
for concern. When the [32P]GPIfree–P-derived Gro-
PIns[32P]phosphate was subjected to SAX-HPLC analysis
two peaks were observed. The former, eluting at 40 min, con-
tained approximately 80% of the total radioactivity in the two
peaks and coincided with the elution of the authentic [32P]Gro-
PIns3P standard. When the phosphorylation of GPIfree was
performed in the presence of the PI3K inhibitors, wortmannin
(100 nM) and LY294002 (10 lM), the formation of GPIfree–P
was signiﬁcantly inhibited (by 73% and 84%, respectively, data
not shown). GPIfree was puriﬁed using multiple TLC steps,
Fig. 3. TLC and SAX-HPLC analysis of the phosphorylation of
GPIAchE-anchor by PI3K. Panel A. Buﬀer (control) and GPIAChE-anchor
were used as substrates for in vitro PI3K phosphorylation. The
radiolabelled product was applied to a TLC plate followed by its
development in a basic solvent system. [32P]GPIAChE-anchor–P migrated
with an Rf of approximately 0.53, coinciding with that of
[32P]PtdIns4P. The migration positions of the authentic phospholipid
standards are indicated. Panel B. [32P]GPIAChE-anchor–P recovered
from the TLC plate was subjected to nitrous acid deamination
followed by its deacylation. The radiolabelled products were then
analyzed by SAX-HPLC. The arrow indicates the minor peak
identiﬁed as [32P]GroPIns3P. The numbers above the SAX-HPLC
proﬁle refer to the position of authentic standards. 1, Gro3P; 2,
inorganic phosphate; 3, GroPIns3P.
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could have led to the generation of [32P]PtdIns3P. Further-
more, the absence of polyunsaturated fatty acids in the GPIfree
preparation (which would have been indicative of the presence
of contaminating PtdIns) was conﬁrmed by GC/MS ( [22,32]
and data not shown). To further conﬁrm that the GPIfree prep-
aration was not contaminated with PtdIns, Class I PI3K was
immunoprecipitated followed by its incubation with GPIfree
in the presence of [c32P]ATP. The reaction products were
deacylated without prior nitrous acid deamination and sub-
jected to analysis by SAX-HPLC. Fig. 2 panel D indicates
the SAX-HPLC proﬁle. No peak corresponding to GroPt-
dIns3P was found to be present, thereby conﬁrming that the
GPIfree preparation was not contaminated with PtdIns. Panel
D also reveals that several peaks of radioactivity were present
in the SAX-HPLC proﬁle (marked with an asterisk) whose
absolute identiﬁcation remains to be determined. These peaks
most likely correspond to a series of diﬀerentially 3-phosphor-
ylated GroPIns-glycan species. This observation of multiply
phosphorylated GPIfree species has been shown previously
and is reﬂected in the chromatographic characteristics of both
IPG [33] and GPIfree [21,34].
After determining that PI3K was able to phosphorylate rat
liver-derived GPIfree, we decided to ascertain whether GPIanchor
was also a substrate for PI3K. GPIanchor isolated from bovine
erythrocyte AChE (GPIAChE-anchor) was incubated with immu-
noprecipitated PI3K and [c32P]ATP. After performing a lipid
extraction, a [32P]labelled product migrated on a TLC plate
with an Rf of approximately 0.53 (Fig. 3, panel A). When an
active recombinant Class I (p85a/p110a) PI3K was used in-
stead of PI3K immunoprecipitated from mammalian cells, a
[32P]labelled product with similar chromatographic properties
was generated (data not shown). The structures of GPIfree
and GPIanchor show both similarities and diﬀerences. The latter
are apparent when their glycan cores are compared [12,35].
Despite this, the Rf of the [
32P] labelled product [putatively
identiﬁed as phosphorylated bovine erythrocyte AChE GPIanchor
(GPIAChE-anchor–P)] was only slightly higher than GPIfree–P
when GPIfree was used as a substrate in an identical in vitro
phosphorylation reacion (Fig. 1). In order to conﬁrm that
the [32P]GPIAChE-anchor–P was indeed 3-phosphorylated, it
was necessary to use the analysis method employed previously.
The [32P]GPIAChE-anchor–P was treated with nitrous acid and
the products were deacylated before analysis by HPLC. Fig.
3 panel B indicates that the majority of the radioactivity eluted
at approximately 30 min. A peak at 40 min was also evident,
which coincided with that of the [32P]GroPIns3P standard.
No peak at 40 min was detected after mock treatment of
[32P]GPIAChE-anchor–P (data not shown). Nitrous acid deami-
nation requires the amino group of the hexosamine residue
to be free, i.e., not substituted. Our ﬁndings that only a small
proportion of [32P]PtdIns3P was liberated from the
[32P]GPIAChE-anchor–P after treatment with nitrous acid is most
likely explained by the fact that the hexosamine residue in the
GPIAChE-anchor is naturally modiﬁed by N-methylation [36],
thereby greatly hindering the nitrous acid deamination reac-
tion. Therefore, the peak of radioactivity eluting from the
HPLC at 40 min corresponds to the proportion of
[32P]GPIAChE-anchor–P sensitive to nitrous acid deamination,
implying that the majority is resistant due to the N-methyla-
tion. Nitrous acid deamination of GPIfree–P proceeds without
hindrance, as the hexosamine residue has no amino group sub-stitutions. Immunoprecipitated PI3K preparations underwent
both analysis by TLC and HPLC to eliminate the possibility
that [32P]PtdIns3P (and hence [32P]GroPIns3P) could have
been generated in incubations in the absence of substrates.
The major peak of radioactivity, which elutes from the HPLC
column at 30 min, coincided with that of the [32P]Gro3P stan-
dard. However, the generation of [32P]PtdOH during the in vi-
tro phosphorylation of GPIAChE-anchor was extremely unlikely
as both immunoprecipitated PI3K and GPIAChE-anchor con-
tained no measurable DAG, immunoprecipitated PI3K con-
tained no diacylglycerol kinase activity and [32P]GPIAChE-
anchor–P migrated on a TLC plate diﬀerently from that of
PtdOH.
Together, these results demonstrate that PI3K is able to 3-
phosphorylate the inositol ring of both GPIfree and at least
one GPIanchor. To the authors knowledge, this is the ﬁrst re-
port of GPI phosphorylation by PI3K. There are many diﬀer-
ent species of GPIanchor, therefore it would be of future interest
to determine if PI3K is able to phosphorylate all of them or
Fig. 4. Time-course of enzymatic cleavage of GPIfree and GPIfree–P.
GPIfree () and GPIfree–P () were subjected to hydrolysis by PI-PLC
(panel A) and GPI-PLD (panel B) at the times indicated. The initial
substrate concentrations were 8 lM (panel A) and 12 lM (panel B).
The enzyme concentration was in both cases 0.16 U/ml.
Fig. 5. Double reciprocal plot of GPI-PLD activity. The substrate was
either GPIfree (O) or GPIfree–P (d). The substrate concentration range
was 5–15 lM. The enzyme concentration was 0.16 U/ml. The
regression line corresponding to the GPIfree experimental points can
be extrapolated to obtain apparent kinetic parameters of KM = 11 lM
and Vmax = 0.25 nmol/min. The experimental points corresponding to
GPIfree–P do not follow a straight line, indicating the non-Michaelan
behaviour of the enzyme in this range of substrate concentrations.
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important molecules in the control of cell proliferation, and
in particular they are both signiﬁcant insulin mediators [10–
13,29–31], the fact that GPIfree can be a substrate of PI3K is
undoubtedly important, and these in vitro observations will
lead to in depth in vivo experiments.
The above results were obtained by using Class I PI3K immu-
noprecipitated from mammalian cells and an active recombi-
nant Class I (p85a/p110a) PI3K. In vivo, the Class I enzyme
is not believed to use PtdIns as a substrate [5], however, in vitro,
PtdIns is preferred over other phosphoinositides. In addition to
the activation of Class I PI3K, insulin is also known to activate
the Class II PI3K, particularly the a isoform [21,37,38]. Class II
PI3K may be associated to membrane subdomains such as cav-
eolae, the same compartment reported to be rich in insulin-sen-
sitive GPIfree [39] and where insulin receptor binding and
initiation of downstream signalling pathways take place
[14,40]. In order to determine if Class II PI3K was able to 3-
phosphorylate GPIfree, we immunoprecipitated the enzyme
from HEK-293 cells [25]. TLC analysis of the reaction products
revealed that Class II PI3Kwas also able to phosphorylate GPI-
free (data not shown). Together, we have conﬁrmed that both
Class I and Class II PI3-K enzymes possessed the ability to
phosphorylate GPIfree in vitro. One major question is where cel-
lular phosphorylation of both GPIfree and GPIanchor could oc-
cur. Our data suggest that both GPIfree and GPIanchor
phosphorylation could occur at submembrane compartments
where the close association between PI3K, speciﬁc phospholip-
ases and their substrates would be facilitated. Diﬀerent in vivo
and in vitro experiments support this hypothesis. Firstly, all
the elements have been reported to be located and even acti-
vated into those compartments [39–46]. Secondly, GPI hydroly-
sis by phospholipases is modulated in vitro by the lipidic
environment [22,26,47]. Thirdly, a recent report indicates the
presence of at least two diﬀerent pools of GPI precursors: the
major one is not used for the synthesis of GPIanchor and is lo-
cated into triton-insoluble microdomains [48] suggesting that
those caveolae-like membrane regions are very rich in GPIfree.
Phospholipases are crucial enzymes for the generation of li-
pid second messengers and the release of water-soluble
phospholipid headgroups. GPIfree is a substrate for several
phospholipases, mainly the parasite GPI-PLC and the mam-
malian GPI-PLD, however the less speciﬁc bacterial enzyme
PI-PLC is also active [12,21,22,26]. In order to study whether
phosphorylation of GPIfree induced any changes in its role as
a substrate for the generation of IPG molecules, GPIfree and
GPIfree–P were separately incorporated asymmetrically in the
outer monolayer of large unilamellar vesicles [26]. The result-
ing liposomes were incubated with either PI-PLC or GPI-
PLD. The time-course of enzyme hydrolysis of GPIfree and
GPIfree–P is shown in Fig. 4. With PI-PLC (Fig. 4 panel A),
GPIfree–P was hydrolyzed to a greater extent than GPIfree,
although the initial rates were rather similar. GPIfree phos-
phorylation had a more marked eﬀect when GPI-PLD was
used (Fig. 4 panel B). Phosphorylation decreased both the rate
and the extent of GPIfree hydrolysis by GPI-PLD. In addition,
hydrolysis of GPIfree–P by this enzyme appears to exhibit a lag
time, although the scarcity of substrate prevented us from car-
rying out more detailed studies. The observations in Fig. 5
were qualitatively similar in experiments at varying substrate
concentrations: PI-PLC-mediated hydrolysis of GPIfree–P
was greater than that for GPIfree. The reverse was found withGPI-PLD. A more detailed study was performed with GPIfree
and GPIfree–P using bovine brain GPI-PLD and substrate con-
centrations in the 5–15 lM concentration range (Fig. 5). The
double-reciprocal plot shows that, when GPIfree was used as
the substrate, GPI-PLD appears to act as a Michaelian en-
zyme, and the data can be adjusted to a straight line whose
extrapolation provides apparent KM and Vmax values of 11
lM and 0.25 nmol/min, respectively. However, with GPIfree–
P as the substrate the rates are consistently slower (note the
diﬀerent Y-axis scale) and the enzyme behaviour is no longer
Michaelian, as revealed by the non-linear experimental data
in the double-reciprocal plot.
The hydrolysis of 3 0-phosphorylated phosphoinositides
(PtdIns3P, PtdIns3,4P2, and PtdIns3,4,5P3) by PLCs is unli-
kely. To date, no such enzyme has neither been proposed
nor cloned from mammalian or any other sources. In contrast,
a family of mammalian PLDs speciﬁcally directed towards
PtdIns3,4,5P3 has been identiﬁed and cloned [49]. However,
its real role, either attenuating the generation of PtdIns3,4,5P3
or the generation of PtdOH or inositol-1,3,4,5-tetrakisphos-
phate, remains unknown. PI3K has been shown to regulate
GPI hydrolysis [50] but through a diﬀerent mechanism, namely
tyrosine phosphorylation of PLC-c 2, a well-established target
of PI3K, in erythropoietin-stimulated cells. Our work has
64 D.R. Jones et al. / FEBS Letters 579 (2005) 59–65focussed on the diﬀerential eﬀects of 3 0-phosphorylation of an
inositol ring on phospholipase activities. At ﬁrst sight, the fact
that GPIfree–P is a better substrate for PI-PLC than GPIfree,
yet is a poorer substrate for GPI-PLD than GPIfree could be
considered contradictory. One explanation for this could be
the requirement for a speciﬁc molecular conformation of GPI-
free or GPIfree–P in the active site of the enzyme for its hydro-
lysis. In the case for PI-PLC, GPIfree–P may give a better ﬁt,
whereas for GPI-PLD the extra phosphate group may be a
hindrance. Another hypothesis centres on the possibility that
GPIfree phosphorylation by PI3K could be a negative feedback
signal that decreases the eﬃciency of GPIfree hydrolysis by
mammalian GPI-PLD.
At a physiological level, further studies will be required to
determine to what extent GPIfree–P is present under resting con-
ditions and if after agonist stimulation the ratio of GPIfree –P to
GPIfree increases or decreases. One could envisage that depend-
ing on the spatial distribution of PI3K and GPIfree-hydrolyzing
phospholipases, GPIfree hydrolysis in response to agonists, such
as insulin, could be carefully controlled depending on its state of
phosphorylation and the localization of phospholipases. In
addition, insulin-stimulation of cells leads to the release of some
GPI-anchored proteins via a mechanism involving an endoge-
nous GPI-PLC [51,52]. The release of such proteins could be
tightly regulated depending on the phosphorylation state of
their GPIanchor. As discussed above, sites at which such events
may occur are the non-clathrin-coated plasma membrane
invaginations termed caveolae, which have been found to con-
tain all the substrates and enzymatic machinery required for
carrying out such processes. This would represent a novel mech-
anism for the regulation of the release of both IPG molecules
and GPI-anchored proteins in a spatial and temporal manner.
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